Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...

On Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA ...

Moderna estimates that a norovirus vaccine has a total addressable market ... vaccine that’s taken as a pill, rather than an injection. It’s currently in early stage human testing of its ...

The lawsuit, filed in federal court in Boston, challenges the Trump administration, the Department of Health and Human Services and the National Institutes of Health over efforts to reduce funding ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to ... assigned to receive a single intramuscular injection of mRNA-1403 or placebo. According to the Company ...

Moderna intends to use the above-mentioned funds to support the late-stage development of mRNA-1018, its investigational pandemic influenza vaccine against H5 and H7 avian influenza viruses.

Moderna begins trialing mRNA shot that is injected directly into the HEART to treat heart attack patients - ...

Moderna (MRNA) cut its 2025 forecast by $1 billion Monday, citing weak demand for its newest vaccine as well as slow sales for its COVID-19 vaccine. The company now expects $1.5 billion to $2 ...

Shares of Moderna plunged 20% Monday after the vaccine maker slashed its forecast of full-year 2025 revenue, as sales of its vaccines against Covid-19 and respiratory syncytial virus continue to ...

Moderna Inc. shares plunged after the company slashed its sales forecast for this year as it struggles with slow demand for its Covid and RSV vaccines. The Cambridge, Massachusetts-based company ...